Form4insider filings, from the source

SEC Form 4 · accession 0001209191-16-124010

PUMA BIOTECHNOLOGY, INC. · PBYI

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Alan H Auerbach
Officer — PRESIDENT AND CEO · Director · 10% Owner
Period of report
May 25, 2016
Accepted (ET)
May 27, 2016 · 4:12 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001401667

Table I — non-derivative securities

No Table I lines on this filing.

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Stock Option (Right to Buy)F1,F2$35.61May 25, 2016A66,667A—May 24, 2026Common Stock66,66766,667D

Explanation of responses